After Adverse Effects, Roche Ends Trials of Diabetes Drug
Sunday, September 12, 2010 - 19:56
in Health & Medicine
Patients reported a high rate of adverse reactions in trials for the experimental drug, which the company had hoped would bring in $2 billion a year.